Stephan Francke

1.7k total citations · 1 hit paper
20 papers, 1.3k citations indexed

About

Stephan Francke is a scholar working on Genetics, Molecular Biology and Pharmacology. According to data from OpenAlex, Stephan Francke has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Stephan Francke's work include Genetic Associations and Epidemiology (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Regulation of Appetite and Obesity (3 papers). Stephan Francke is often cited by papers focused on Genetic Associations and Epidemiology (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Regulation of Appetite and Obesity (3 papers). Stephan Francke collaborates with scholars based in United States, France and United Kingdom. Stephan Francke's co-authors include Philippe Froguel, Christian Dina, Emmanuelle Durand, Cécile Lecœur, Frédéric Leprêtre, S. Dupont, Nathalie Vionnet, El Habib Hani, Sophie Gallina and Vincent Vatin and has published in prestigious journals such as Nature Genetics, Diabetes and Oncogene.

In The Last Decade

Stephan Francke

20 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomewide Search for Type 2 Diabetes–Susceptibility Genes in French Whites: Evidence for a Novel Susceptibility Locus for Early-Onset Diabetes on Chromosome 3q27-qter and Independent Replication of a Type 2–Diabetes Locus on Chromosome 1q21–q24

2000 576 citations Nathalie Vionnet, El Habib Hani et al. The American Journal of Human Genetics profile →

Peers

Countries citing papers authored by Stephan Francke

Since Specialization

Citations

This map shows the geographic impact of Stephan Francke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Francke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Francke more than expected).

Fields of papers citing papers by Stephan Francke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Francke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Francke. The network helps show where Stephan Francke may publish in the future.

Co-authorship network of co-authors of Stephan Francke

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Francke. A scholar is included among the top collaborators of Stephan Francke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Francke. Stephan Francke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Common Variants on FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF Trial 2023 ·Circulation Heart Failure ·Hongsheng Gui, W.H. Wilson Tang, Stephan Francke, Jia Li, Ruicong She, Peter Bazeley, Naveen L. Pereira, Kirkwood F. Adams, Jasmine A. Luzum, Thomas Connolly, Adrian F. Hernandez, Candace D. McNaughton, L. Keoki Williams, David E. Lanfear	7
2	Genome-wide association study of abnormal elevation of ALT in patients exposed to atabecestat 2023 ·BMC Genomics ·Qingqin S. Li, Stephan Francke, Jan Snoeys, John Thipphawong, Gary Romano, Gerald Novak	4
3	Tramadol Hydrochloride at Steady State Lacks Clinically Relevant QTc Interval Increases in Healthy Adults 2018 ·Clinical Pharmacology in Drug Development ·Joseph Massarella, Jay Ariyawansa, Jaya Natarajan, Stephan Francke, (unknown), (unknown), (unknown), (unknown)	11
4	An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma 2016 ·Oncogene ·(unknown), (unknown), (unknown), (unknown), Stephan Francke, Pascal Wolter, Stefanie Hauser, Daniel J. Murphy, Paloma García, Andreas Rosenwald, Stefan Gaubatz	35
5	A candidate-gene association study of topiramate-induced weight loss in obese patients with and without type 2 diabetes mellitus 2015 ·Pharmacogenetics and Genomics ·Qingqin S. Li, James M. Lenhard, Yiping Zhan, (unknown), Μαρία Αθανασίου, Richard Strauß, Stephan Francke	13
6	In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humans 2015 ·The Journal of Clinical Pharmacology ·Stephan Francke, Rao N. V. S. Mamidi, Bhavna Solanki, Ellen Scheers, (unknown), Reyna Favis, Damayanthi Devineni	41
7	The Role of ADME Pharmacogenomics in Early Clinical Trials: Perspective of the Industry Pharmacogenomics Working Group (I-PWG) 2015 ·Pharmacogenomics ·Larry M. Tremaine, William R. Brian, Terrye Delmonte, Stephan Francke, Peter Groenen, Keith Johnson, Lei Li, (unknown), Jean‐Claude Marshall	21
8	The effect ofUGT2B72polymorphism on the pharmacokinetics of OROS® hydromorphone in Taiwanese subjects 2014 ·The Journal of Clinical Pharmacology* ·Joris Vandenbossche, (unknown), Stephan Francke, An Van den Bergh, (unknown), (unknown)	8
9	Rare variant collapsing in conjunction with mean log p-value and gradient boosting approaches applied to Genetic Analysis Workshop 17 data 2011 ·BMC Proceedings ·(unknown), Nandini Raghavan, Stephan Francke, Frank DeFalco, Marsha Wilcox	2
10	Robust physical methods that enrich genomic regions identical by descent for linkage studies: confirmation of a locus for osteogenesis imperfecta 2009 ·BMC Genetics ·Peter Brooks, Charles Marcaillou, (unknown), Jean‐Paul Saraiva, Daniel Stockholm, Stephan Francke, Reyna Favis, Nadine Cohen, Francis Rousseau, Frédéric Torès, Pierre Lindenbaum, Jörg Hager, Anne Philippi	6
11	Case–Control Study of the Association Between Select HLA Genes and Anti-Erythropoietin Antibody-Positive Pure Red-Cell Aplasia 2008 ·Pharmacogenomics ·Bonnie A. Fijal, Deborah Ricci, Els Vercammen, Peter Palmer, Fotis Fotiou, Daniel Fife, Anders Lindholm, (unknown), Stephan Francke, Xiaodong Wu, (unknown), Nadine Cohen	8
12	Effect of CYP2D6 genetic polymorphism on the population pharmacokinetics of tipifarnib 2006 ·Cancer Chemotherapy and Pharmacology ·Juan José Pérez Ruixo, Peter Zannikos, Vural Özdemir, (unknown), Stephan Francke, Vladimir Piotrovsky	7
13	A Genome-Wide Scan for Childhood Obesity–Associated Traits in French Families Shows Significant Linkage on Chromosome 6q22.31-q23.2 2004 ·Diabetes ·Stephen Eyre, Cécile Lecœur, Jérôme Delplanque, Stephan Francke, Vincent Vatin, Emmanuelle Durand, Jacques Weill, Christian Dina, Philippe Froguel	111
14	P4-161 Impact of APOE genotype on the efficacy of galantamine for the treatment of mild cognitive impairment 2004 ·Neurobiology of Aging ·Michael Gold, Stephan Francke, Jeffrey S. Nye, (unknown), Bonnie A. Fijal, Luc Truyen, Nadine Cohen	13
15	TAK-677 (Dainippon/Takeda). 2002 ·PubMed ·Stephan Francke	4
16	Genetic and environmental nature of the insulin resistance syndrome in Indo-Mauritian subjects with premature coronary heart disease: contribution of β3-adrenoreceptor gene polymorphism and beta blockers on triglyceride and HDL concentrations 2001 ·Diabetologia ·(unknown), Stephan Francke, (unknown), (unknown), Philippe Froguel	13
17	Genomewide Search for Type 2 Diabetes–Susceptibility Genes in French Whites: Evidence for a Novel Susceptibility Locus for Early-Onset Diabetes on Chromosome 3q27-qter and Independent Replication of a Type 2–Diabetes Locus on Chromosome 1q21–q24 breakdown → 2000 ·The American Journal of Human Genetics ·Nathalie Vionnet, El Habib Hani, S. Dupont, Sophie Gallina, Stephan Francke, (unknown), (unknown), Emmanuelle Durand, Frédéric Leprêtre, Cécile Lecœur, (unknown), (unknown), Christian Dina, Philippe Froguel	576
18	A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10 1998 ·Nature Genetics ·Jörg Hager, Christian Dina, Stephan Francke, Séverine Dubois, (unknown), Vincent Vatin, Emmanuel Vaillant, Nathalie Lorentz, Arnaud Basdevant, Karine Clément, B Guy-Grand, Philippe Froguel	292
19	A polymorphism in the 5′ untranslated region of the human ob gene is associated with low leptin levels 1998 ·International Journal of Obesity ·Jörg Hager, Karine Clément, Stephan Francke, Christian Dina, (unknown), N. Lahlou, (unknown), Véronique Pelloux, A Basdevant, B Guy-Grand, Michael North, Philippe Froguel	105
20	Genetic studies of the leptin receptor gene in morbidly obese French Caucasian families 1997 ·Human Genetics ·Stephan Francke, Karine Clément, Christian Dina, Hiroshi Inoue, P Behn, Vincent Vatin, Arnaud Basdevant, B Guy-Grand, M. Alan Permutt, Philippe Froguel, Jörg Hager	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact